Ketanserin treatment and serotonin in patients with primary and secondary Raynaud's phenomenon. 1988

B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
Clinica Medica V, Ospedale S. Paolo, Università degli Studi, Milano, Italy.

In a double-blind, placebo cross-over study in 14 patients with Raynaud's disease, oral ketanserin 40 mg b.d. for two months reduced the number of digital ischaemic attacks in 36% of the patients, with no difference between primary or secondary cases. Intraplatelet and circulating serotonin concentrations were significantly higher in patients than in controls. During treatment there was a significant decrease in intraplatelet serotonin, but no change in circulating serotonin or in the amount of serotonin released by platelets in vitro. The results suggest that oral ketanserin is of minor help in Raynaud's phenomenon and they support a role for serotonin in the disorder.

UI MeSH Term Description Entries
D007650 Ketanserin A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione,R-41,468,R-41468,R 41,468,R 41468,R41,468,R41468
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
October 1984, British medical journal (Clinical research ed.),
B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
January 1987, VASA. Zeitschrift fur Gefasskrankheiten,
B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
January 1984, Journal of cardiovascular pharmacology,
B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
July 1987, Angiology,
B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
September 1984, British medical journal (Clinical research ed.),
B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
April 2023, Journal of clinical medicine,
B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
May 2008, Zeitschrift fur Rheumatologie,
B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
June 1990, Journal of cardiovascular pharmacology,
B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
January 1988, Drugs,
B Marasini, and M L Biondi, and E Bianchi, and P Dell'Orto, and A Agostoni
January 1987, VASA. Supplementum,
Copied contents to your clipboard!